Active Not Recruiting NA INTERVENTIONAL 1-arm NCT06418919

A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.

Sponsor: The University of Hong Kong

Conditions Radiofrequency Ablation Treatment Relapsed Graves' Disease Thyroid; Functional Disturbance

Interventions Radiofrequency ablation treatment

Updated 3 times since 2024 Last updated: May 29, 2024 Started: Mar 1, 2020 Primary completion: Jun 1, 2025 Completion: Dec 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06418919, this NA trial focuses on Radiofrequency Ablation Treatment and Relapsed Graves' Disease and remains ongoing. Sponsored by The University of Hong Kong, it has been updated 3 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Active Not Recruiting NA

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Hong Kong

Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong